Tarsus joins Stargardt race to market with $800m Alkeus takeover
Alongside Alkeus, companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargardt market with no approved drugs.
Read the full article on the original site.
Read Full Article